Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (211-220 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Investigation|October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexateG A Curt, J Jolivet, D N Carney, et al.
Annals of Internal Medicine|March 1, 1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapyR I Fisher, V T DeVita, S M Hubbard, et al.
Cancer|December 15, 1982
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer InstituteT Anderson, B A Chabner, R C Young, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
AntimetabolitesE Chu, P G Johnston, C H Takimoto, et al.
The Oncologist|May 5, 2000
Communicating genetic risk: pros, cons, and counselR T Penson, M V Seiden, K M Shannon, et al.
Annals of Internal Medicine|August 1, 1976
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphomaB A Chabner, R E Johnson, R C Young, et al.
The Journal of Infectious Diseases|May 1, 1987
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondiiJ A Kovacs, C J Allegra, B A Chabner, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
AntimetabolitesJ L Grem, C H Takimoto, P Multani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCHM Gutierrez, B A Chabner, D Pearson, et al.
The Journal of Clinical Investigation|September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?B A Chabner, C J Allegra, G A Curt, et al.
Pageof 25

Showing results (211-220 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|October 1, 1985
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexateG A Curt, J Jolivet, D N Carney, et al.
Annals of Internal Medicine|March 1, 1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapyR I Fisher, V T DeVita, S M Hubbard, et al.
Cancer|December 15, 1982
Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer InstituteT Anderson, B A Chabner, R C Young, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
AntimetabolitesE Chu, P G Johnston, C H Takimoto, et al.
The Oncologist|May 5, 2000
Communicating genetic risk: pros, cons, and counselR T Penson, M V Seiden, K M Shannon, et al.
Annals of Internal Medicine|August 1, 1976
Sequential nonsurgical and surgical staging of non-Hodgkin's lymphomaB A Chabner, R E Johnson, R C Young, et al.
The Journal of Infectious Diseases|May 1, 1987
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondiiJ A Kovacs, C J Allegra, B A Chabner, et al.
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
AntimetabolitesJ L Grem, C H Takimoto, P Multani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCHM Gutierrez, B A Chabner, D Pearson, et al.
The Journal of Clinical Investigation|September 1, 1985
Polyglutamation of methotrexate. Is methotrexate a prodrug?B A Chabner, C J Allegra, G A Curt, et al.
Pageof 25